| Financial Year |
March 31 2023 |
| Monetary Funds |
94,601,638.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
187,232,186.20 |
| Accounts Receivable |
431,583,506.43 |
| Advances to Suppliers |
23,952,716.02 |
| Other Receivables |
3,228,064.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
514,229,092.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,568,579.97 |
| Total Current Assets |
1,370,688,737.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,101,562,813.00 |
| Under-construction Projects |
261,728,293.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
221,168,451.62 |
| R&D expenses |
19,033,199.51 |
| Goodwill |
97,190,686.92 |
| Long-Term Deferred and Prepaid Expenses |
17,644,158.93 |
| Deferred Income Tax Assets |
44,075,974.33 |
| Other Non-Current Assets |
65,152,031.31 |
| Sub-Total of Non-Current Assets |
1,833,055,390.93 |
| Total Assets |
3,203,744,128.72 |
| Short-Term Loans |
637,308,529.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
142,456,583.67 |
| Accounts Payable |
364,678,746.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,822,535.42 |
| Taxes Payable |
5,464,915.00 |
| Interest Payable |
-- |
| Dividend Payable |
1,261,708.93 |
| Other payables |
32,097,309.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
92,714,112.10 |
| Other Current Liabilities |
342,521.81 |
| Sub-Total of Current Liabilities |
1,297,706,239.24 |
| Long-term Loans |
137,512,478.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,188,240.16 |
| Deferred Income Tax Liabilities |
23,542,180.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
208,357,893.00 |
| Total Liabilities |
1,506,064,132.24 |
| Paid-In Capital(Or Share Stock) |
358,730,089.00 |
| Capital Surplus |
1,016,918,353.72 |
| Surplus Reserve |
41,906,186.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
282,590,711.70 |
| Minority Stockholder's Interest |
123,728,805.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,573,951,191.46 |
| Owner's Equity（Stockholder's Equity） |
1,697,679,996.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,203,744,128.72 |
